mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
AZD-7545 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.004 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |